Literature DB >> 1488963

Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak.

J R Glynn1, S R Palmer.   

Abstract

The associations between infecting dose, incubation period, and the severity of disease were examined in a large outbreak of Salmonella typhimurium which occurred at a medical conference in Wales in 1986. Persons who had eaten two or more pieces of the chicken vehicle had, on average, shorter geometric mean incubation periods than those who had only eaten one piece: 16.6 hours (95% confidence interval (CI) 13.5-20.5) compared with 20.7 hours (95% CI 19.0-22.6) (t = 1.97, p < 0.05). Incubation period was negatively correlated with the maximum frequency of diarrheal stools (r = -0.46, 95% CI -0.56 to -0.33), the maximum temperature reached (r = -0.34, 95% CI -0.50 to -0.16), the duration of symptoms (r = -0.41, 95% CI -0.53 to -0.26), and the amount of time taken off from work (r = -0.54, 95% CI -0.65 to -0.41). Those with shorter incubation periods were more likely to have been hospitalized. There was no association between chicken consumption and any of the measures of severity. The authors discuss the evidence that incubation period is inversely related to dose, the use of incubation period as a marker for dose, and the role that individual differences in susceptibility play in determining both the incubation period and the outcome.

Entities:  

Mesh:

Year:  1992        PMID: 1488963     DOI: 10.1093/oxfordjournals.aje.a116449

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

Review 1.  Host specificity of bacterial pathogens.

Authors:  Andreas Bäumler; Ferric C Fang
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

2.  Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used.

Authors:  J R Glynn; R B Hornick; M M Levine; D J Bradley
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

Review 3.  How to become a top model: impact of animal experimentation on human Salmonella disease research.

Authors:  Renée M Tsolis; Mariana N Xavier; Renato L Santos; Andreas J Bäumler
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

Review 4.  Now you see me, now you don't: the interaction of Salmonella with innate immune receptors.

Authors:  A Marijke Keestra-Gounder; Renée M Tsolis; Andreas J Bäumler
Journal:  Nat Rev Microbiol       Date:  2015-03-09       Impact factor: 60.633

5.  Dose-response effects in an outbreak of Salmonella enteritidis.

Authors:  E D Mintz; M L Cartter; J L Hadler; J T Wassell; J A Zingeser; R V Tauxe
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

Review 6.  Typhoid fever: "you can't hit what you can't see".

Authors:  Tamding Wangdi; Sebastian E Winter; Andreas J Bäumler
Journal:  Gut Microbes       Date:  2012-03-01

Review 7.  Typhoidal and non-typhoidal Salmonella infections in Africa.

Authors:  S I Smith; A Seriki; A Ajayi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-25       Impact factor: 3.267

8.  The flagellar regulator TviA reduces pyroptosis by Salmonella enterica serovar Typhi.

Authors:  Sebastian E Winter; Maria G Winter; Vidya Atluri; Victor Poon; Everton L Romão; Renée M Tsolis; Andreas J Bäumler
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

9.  Neutrophils are a source of gamma interferon during acute Salmonella enterica serovar Typhimurium colitis.

Authors:  Alanna M Spees; Dawn D Kingsbury; Tamding Wangdi; Mariana N Xavier; Renée M Tsolis; Andreas J Bäumler
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

10.  Non-Typhoidal Salmonella and the Risk of Kawasaki Disease: A Nationwide Population-Based Cohort Study.

Authors:  Thomas Yen-Ting Chen; Mei-Chia Chou; Jung-Nien Lai; Lu-Ting Chiu; Renin Chang; Yao-Min Hung; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.